Editorial: New Advances in Cardiorenal Syndrome

被引：1

作者：

Calvier, Laurent ^{[1
,2
]}

Kokeny, Gabor ^{[3
,4
]}

Martinez-Martinez, Ernesto ^{[5
,6
]}

机构：

[1] Univ Texas Southwestern Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA

[2] Univ Texas Southwestern Med Ctr, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA

[3] Semmelweis Univ, Inst Translat Med, Budapest, Hungary

[4] Semmelweis Univ, Int Nephrol Res & Training Ctr, Budapest, Hungary

[5] Univ Complutense Madrid, Fac Med, Dept Fisiol, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain

[6] Inst Salud Carlos III, Ciber Enfermedades Cardiovasc, Madrid, Spain

来源：

FRONTIERS IN CARDIOVASCULAR MEDICINE | 2022年 / 9卷

关键词：

cardiorenal syndrome; cardiovascular system; heart failure; kidney failure; inflammation; fibrosis; mitochondria; biomarker; PPAR-GAMMA; GALECTIN-3; INHIBITION; CARDIOTROPHIN; ALDOSTERONE; HYPERTENSION; FIBROSIS;

D O I：

10.3389/fcvm.2022.976846

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 22 条

[21] The PPARγ agonist pioglitazone prevents TGF-β induced renal fibrosis by repressing EGR-1 and STAT3 [J].

Nemeth, Agnes ;

Mozes, Miklos M. ;

Calvier, Laurent ;

Hansmann, Georg ;

Kokeny, Gabor .

BMC NEPHROLOGY, 2019, 20 (1)

[22] Cardiorenal syndrome: Multi-organ dysfunction involving the heart, kidney and vasculature [J].

Savira, Feby ;

Magaye, Ruth ;

Liew, Danny ;

Reid, Christopher ;

Kelly, Darren J. ;

Kompa, Andrew R. ;

Sangaralingham, S. Jeson ;

Burnett, John C., Jr. ;

Kaye, David ;

Wang, Bing H. .

BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (13) :2906-2922

← 1 2 3 →